STAB

Statera Biopharma, Inc. Common Stock
STAB

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

STAB was delisted on the 11th of January, 2023.

Back to rankings

16 hedge funds and large institutions have $1.49M invested in Statera Biopharma, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$57.1K
2
+$41K
3
+$39.5K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$36K
5
UBS Group
UBS Group
Switzerland
+$12K

Top Sellers

1
-$42K
2
-$9.23K
3
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$797K
2
$514K
3
$50K
4
$41K
5
$36K
6
$35K
7
$12K
8
$1K
9
–
10
–